OpenVSafe by OpenVAERS
Search V-safe

9LK-12634-36383

4 vaccinations 7 coded responses 22 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
51-55
ZIP prefix
165 / PA
Registered
2021-03-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2516747 (opens in a new window) high 11 / 11 3 4 of 5 VAERS symptoms same dose (4) PA matches 2022-05-24 / 2022-07-07 / 2022-11-25
received the same day as the last call
case 1186272

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-27
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-30
    Registered in v-safe
  4. 2021-03-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyskinesia — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Jerky movements of hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Severe fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Fatigue — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Severe fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-03
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  9. 2021-04-10
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-17
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-01
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-05-08
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-06-26
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-09-25
    Survey response — 6 months, dose 2
    MedDRA: Nausea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Bad nausea
    MedDRA releases: 2024-11 · check-in free text available
  16. 2021-11-05
    Dose 3 — Janssen/Johnson & Johnson
  17. 2022-03-27
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-05-24
    Dose 4 — Pfizer-BioNTech
  19. 2022-06-02
    Health check-in — day 7, dose 4
    Feeling: Fair · Site: Pain · None
    Adult check-in
  20. 2022-06-07
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  21. 2022-06-14
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  22. 2022-06-21
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  23. 2022-06-28
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  24. 2022-07-05
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  25. 2022-08-23
    Survey response — 3 months, dose 4
    MedDRA: Ageusia, Anosmia, Arthralgia, Cough, Diarrhoea, Headache, Migraine, Oropharyngeal pain, Pain, Paranasal sinus hypersecretion, Pyrexia, Spinal pain — Feeling: Good · Be unable to do your normal daily activities
    Free text: Sore throat, fever, cough, spinal pain, migraine and headaches, intense body pain, diarrhea, joint pain (VERY INTENSE!!), loss of taste and smell, sinus drainage
    MedDRA releases: 2024-11 · check-in free text available
  26. 2022-11-22
    Survey response — 6 months, dose 4
    MedDRA: Cognitive disorder, Condition aggravated, Fatigue, Memory impairment, Migraine, Nervous system disorder, Pre-existing disease, Pulmonary function test decreased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Increased fatigue, memory/cognition issues increased, increased nervous system reactions, migraine issues increased, decreased lung function and more dependent on long term inhalers (from prn use to twice daily use).
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-11-22
    Report sent to call center — 6 months, dose 4
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2022-11-23
  29. 2022-11-25
  30. 2022-11-25
    Call successful
    Completed over the phone
  31. 2023-05-24
    Survey response — 12 months, dose 4
    MedDRA: Malaise — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12021-03-06Pfizer-BioNTech
22021-03-27Pfizer-BioNTech
32021-11-05Janssen/Johnson & Johnson No
42022-05-24Pfizer-BioNTech No

Call center

1 call center case

1 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-31

Systemic reaction (other): Jerky movements of hands

2021-04-01

Systemic reaction (other): Severe fatigue

2021-04-02

Systemic reaction (other): Severe fatigue

Release 9 — 6 months, dose 2

2021-09-25

Symptoms: Bad nausea

Release 12 — 3 months, dose 4

2022-08-23

Symptoms: Sore throat, fever, cough, spinal pain, migraine and headaches, intense body pain, diarrhea, joint pain (VERY INTENSE!!), loss of taste and smell, sinus drainage

Release 12 — 6 months, dose 4

2022-11-22

Symptoms: Increased fatigue, memory/cognition issues increased, increased nervous system reactions, migraine issues increased, decreased lung function and more dependent on long term inhalers (from prn use to twice daily use).

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDArthralgia · · ✓
SDCognitive disorder · · ✓
SDCondition aggravated · · ✓
SDCough · · ✓
SDDiarrhoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDMemory impairment · · ✓
SDMigraine · · ✓
SDNausea · · ✓
SDNervous system disorder · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDParanasal sinus hypersecretion · · ✓
SDPre-existing disease · · ✓
SDPulmonary function test decreased · · ✓
SDPyrexia · · ✓
SDSpinal pain · · ✓
SRODyskinesia ✓ ✓ ✓
SROFatigue ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release